Meros Investment Management LP boosted its holdings in InMode Ltd. (NASDAQ:INMD – Free Report) by 10.0% in the fourth quarter, HoldingsChannel.com reports. The firm owned 404,453 shares of the healthcare company’s stock after buying an additional 36,866 shares during the quarter. InMode comprises about 2.4% of Meros Investment Management LP’s investment portfolio, making the stock its 20th largest holding. Meros Investment Management LP’s holdings in InMode were worth $5,941,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Leonteq Securities AG acquired a new position in InMode in the fourth quarter valued at approximately $26,000. Quadrant Capital Group LLC boosted its holdings in InMode by 127.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,945 shares of the healthcare company’s stock valued at $29,000 after purchasing an additional 1,091 shares in the last quarter. Advisory Services Network LLC acquired a new position in InMode in the third quarter valued at approximately $37,000. Basepoint Wealth LLC acquired a new position in InMode in the fourth quarter valued at approximately $39,000. Finally, Deutsche Bank AG boosted its holdings in InMode by 35.9% in the fourth quarter. Deutsche Bank AG now owns 3,927 shares of the healthcare company’s stock valued at $58,000 after purchasing an additional 1,037 shares in the last quarter. 68.04% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
INMD has been the subject of a number of research analyst reports. Robert W. Baird lowered their price target on InMode from $17.00 to $14.00 and set a “neutral” rating for the company in a report on Thursday, May 7th. Barclays set a $19.00 price objective on InMode and gave the company an “overweight” rating in a report on Thursday, May 7th. One equities research analyst has rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $16.00.
InMode Price Performance
InMode stock opened at $13.57 on Tuesday. The business has a 50 day simple moving average of $13.92 and a 200-day simple moving average of $14.16. InMode Ltd. has a 12 month low of $12.72 and a 12 month high of $16.74. The stock has a market capitalization of $859.80 million, a PE ratio of 9.98 and a beta of 1.94.
InMode (NASDAQ:INMD – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The healthcare company reported $0.25 EPS for the quarter, missing analysts’ consensus estimates of $0.30 by ($0.05). The firm had revenue of $82.02 million for the quarter, compared to analysts’ expectations of $79.84 million. InMode had a return on equity of 13.47% and a net margin of 23.27%.The firm’s quarterly revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.31 EPS.
About InMode
InMode Ltd. (NASDAQ:INMD) is a medical technology company headquartered in Israel that develops, manufactures and markets devices for aesthetic and medical treatments. The company specializes in energy-based technologies, primarily radiofrequency platforms, designed to deliver minimally-invasive and non-invasive procedures.
InMode’s product portfolio encompasses a range of modular systems targeting body contouring, facial rejuvenation, skin tightening and other cosmetic applications. Key offerings include devices built on proprietary radiofrequency and radiofrequency-assisted lipolysis, enabling physicians to perform treatments such as tissue coagulation, skin resurfacing and subdermal volumizing with reduced downtime.
The company distributes its technologies through direct sales operations and distribution partners, serving medical professionals across multiple geographies including North America, Europe, Asia Pacific and Latin America.
Further Reading
- Five stocks we like better than InMode
- Can D-Wave Hold Its Own Against 2 Fast-Growing Rivals?
- 3 AI Stocks With Moats That Could Outlast Summer Volatility
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
Want to see what other hedge funds are holding INMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InMode Ltd. (NASDAQ:INMD – Free Report).
Receive News & Ratings for InMode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InMode and related companies with MarketBeat.com's FREE daily email newsletter.
